Pierre Giglio to Female
This is a "connection" page, showing publications Pierre Giglio has written about Female.
Connection Strength
0.179
-
Early assessment of recurrent glioblastoma response to bevacizumab treatment by diffusional kurtosis imaging: a preliminary report. Neuroradiol J. 2019 Oct; 32(5):317-327.
Score: 0.036
-
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma. Cancer. 2012 Jul 15; 118(14):3599-606.
Score: 0.021
-
Syncope and head CT scans in the emergency department. Emerg Radiol. 2005 Dec; 12(1-2):44-6.
Score: 0.014
-
Neoplastic meningitis in patients with adenocarcinoma of the gastrointestinal tract. Cancer. 2005 Jun 01; 103(11):2355-62.
Score: 0.013
-
Case 2: an irresistible urge to sleep. MedGenMed. 2004 Aug 31; 6(3):45.
Score: 0.013
-
Response of neoplastic meningitis from solid tumors to oral capecitabine. J Neurooncol. 2003 Nov; 65(2):167-72.
Score: 0.012
-
Dose-escalated accelerated hypofractionation for elderly or frail patients with a newly diagnosed glioblastoma. J Neurooncol. 2022 Jan; 156(2):399-406.
Score: 0.011
-
Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas. PLoS One. 2020; 15(12):e0244383.
Score: 0.010
-
False-positive 1p/19q Testing Results in Gliomas: Clinical and Research Consequences. Am J Clin Oncol. 2020 11; 43(11):802-805.
Score: 0.010
-
Perilesional apparent diffusion coefficient in the preoperative evaluation of glioma grade. Clin Imaging. 2018 Nov - Dec; 52:88-94.
Score: 0.008
-
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. Neuro Oncol. 2015 Feb; 17(2):266-73.
Score: 0.006
-
Neurological deficits during treatment with tumor necrosis factor-alpha antagonists. Am J Med Sci. 2011 Nov; 342(5):352-5.
Score: 0.005
-
Glioneuronal tumor with neuropil-like islands of the spinal cord with diffuse leptomeningeal neuraxis dissemination. J Neurooncol. 2011 Sep; 104(2):529-33.
Score: 0.005
-
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma. Neuro Oncol. 2010 Nov; 12(11):1167-72.
Score: 0.005
-
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme. Neuro Oncol. 2008 Apr; 10(2):216-22.
Score: 0.004
-
Brain tumors in individuals with familial adenomatous polyposis: a cancer registry experience and pooled case report analysis. Cancer. 2007 Feb 15; 109(4):761-6.
Score: 0.004
-
Hyperkinetic seizures in children. J Child Neurol. 2003 Aug; 18(8):517-24.
Score: 0.003